Viewing Study NCT02596035


Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2026-01-09 @ 6:15 PM
Study NCT ID: NCT02596035
Status: COMPLETED
Last Update Posted: 2022-10-27
First Post: 2015-11-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma
Sponsor: Bristol-Myers Squibb
Organization: